NeuroSense Therapeutics Ltd. Fair Value Adjustment of Warrants
NeuroSense Therapeutics Ltd. (NRSN) reported Fair Value Adjustment of Warrants of -$46.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-03-31
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 12 month |
|---|---|---|
| 2024-12-31 | -$46.00K 20-F · filed 2026-03-31 | |
| 2024-06-26 | $1.70M 6-K · filed 2024-09-30 | |
| 2023-12-31 | -$2.19M 20-F · filed 2026-03-31 | |
| 2023-06-22 | $3.60M 6-K · filed 2024-06-17 |